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 Twist1 and the closely related  twist2 (also 
known as  dermo1 ) genes encode basic helix-
loop-helix transcription factors involved in the 
formation of mesoderm in  Drosophila melano-
gaster ( 1 ), cranial neural tube and limb morpho-
genesis in mice ( 2 ), metastasis of tumor cells ( 3 ), 
control of apoptosis, and expression of cyto-
kine genes in infl ammation ( 4, 5 ). Mice defi -
cient for  twist2 or haploinsuffi  cient for both 
 twist1 and  twist2 succumb to severe systemic 
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 The basic helix-loop-helix transcriptional repressor  twist1 , as an antagonist of nuclear 
factor   B (NF-  B) – dependent cytokine expression, is involved in the regulation of infl am-
mation-induced immunopathology. We show that  twist1 is expressed by activated T helper 
(Th) 1 effector memory (EM) cells. Induction of  twist1 in Th cells depended on NF-  B, 
nuclear factor of activated T cells (NFAT), and interleukin (IL)-12 signaling via signal 
transducer and activator of transcription (STAT) 4. Expression of  twist1 was transient after 
T cell receptor engagement, and increased upon repeated stimulation of Th1 cells. Imprint-
ing for enhanced  twist1 expression was characteristic of repeatedly restimulated EM Th 
cells, and thus of the pathogenic memory Th cells characteristic of chronic infl ammation. 
Th lymphocytes from the infl amed joint or gut tissue of patients with rheumatic diseases, 
Crohn ’ s disease or ulcerative colitis expressed high levels of  twist1 . Expression of  twist1 in 
Th1 lymphocytes limited the expression of the cytokines interferon-  , IL-2, and tumor 
necrosis factor-  , and ameliorated Th1-mediated immunopathology in delayed-type hyper-
sensitivity and antigen-induced arthritis. 
© Niesner et al. This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the fi rst six months after the 
publication date (see http://www.jem.org/misc/terms.shtml). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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T lymphocytes expressing the transgenic DO11.10 TCR 
specifi c for OVA were activated in vitro with splenic APCs 
and the cognate peptide OVA 327-339 under conditions that 
induce functional diff erentiation into Th1 cells, i.e., addi-
tion of IL-12 and blocking antibodies specifi c for IL-4. The 
transcriptional profi les of once- and four-time – stimulated 
Th1 cells were compared using high-density DNA microar-
rays. Among the 17 genes diff erentially expressed by a factor 
of two or more was  twist1 . Expression of  twist1 was up-regu-
lated 38-fold in four-time – versus once-stimulated Th1 cells 
(Table S1, available at http://www.jem.org/cgi/content/full/
jem.20072468/DC1). 
 Twist1 expression in Th1, but not Th2 or Th17, cells was 
confi rmed by real-time PCR ( Fig. 1 ).  Twist1 mRNA expres-
sion in resting Th1 cells correlated with their age in vitro and 
the number of restimulations they had experienced. Expres-
sion was further enhanced 3 h after polyclonal stimulation ei-
ther with PMA and the Ca 2+ ionophore ionomycin, or with 
CD3- and CD28-specifi c antibodies ( Fig. 1 A ). When deter-
mined 3 h after restimulation with anti-CD3/-CD28 anti-
bodies, expression of  twist1 was close to the detection limit in 
naive Th cells. Expression increased   15-fold during the fi rst 
Th1-polarizing stimulation, another 10-fold during the sec-
ond stimulation, and another 3-fold during the third stimula-
tion, reaching the maximum level after the fourth stimulation 
and remaining stable thereafter ( Fig. 1 A ). With PMA/iono-
mycin restimulation, maximum levels of  twist1 mRNA were 
reached after two rounds of stimulation. In Th1 cells, upon 
anti-CD3/-CD28 restimulation,  twist1 mRNA expression was 
up-regulated within the fi rst hour, reaching maximum levels 
after 3 h, and decreasing again thereafter ( Fig. 1 B ). Expression 
of  twist1 mRNA was also detectable in restimulated Th2 cells, 
but its level remained 30-fold lower than in Th1 cells. In Th17 
cells, the level of  twist1 mRNA expression was even lower than 
in Th2 cells ( Fig. 1 C ). 
 Twist1 protein was detectable in 6-d-old restimulated 
Th1 cells. In 24-d-old Th1 cells, expression was enhanced. 
In resting Th1 cells and in reactivated or resting Th2 cells, 
Twist1 was not detectable by immunoblotting ( Fig. 1 D ). In 
agreement with the expression of  twist1 mRNA, Twist1 pro-
tein expression peaked 3 h after reactivation, and then ceased, 
with levels still detectable 48 h after restimulation ( Fig. 1 E ), 
but not at 6 d after restimulation. 
 Twist2 was not expressed in the Th1 and Th2 cells analyzed 
here, as determined by real-time PCR (unpublished data). 
 Control of  twist1 expression in Th1 lymphocytes 
 The specifi c expression of  twist1 by activated Th1 cells sug-
gests that Th1-polarizing or Th1-specifi c signals are required for 
the induction of  twist1 expression in Th cells. Indeed, IL-12/
STAT4 signaling induced  twist1 expression in a dose-dependent 
fashion ( Fig. 2 A ). IFN-  and STAT1 signaling did not induce 
 twist1 expression in the absence of IL-12 ( Fig. 2 A ). T-bet, a 
T box transcription factor suffi  cient to induce Th1 diff erentia-
tion ( 19 ), is not required for induction of expression of  twist1 ; 
induction  of twist1 by IL-12 was comparable in T-bet – defi cient 
infl ammation, demonstrating the central role of Twist pro-
teins in the regulation of infl ammation.  Twist1 and  twist2 are 
expressed by fi broblasts and macrophages, and expression is 
promoted by TNF-  and type I IFNs ( 4, 5 ). The involve-
ment of Twist expression by fi broblasts and macrophages in 
the control of infl ammation is probable, but has not been in-
vestigated in detail so far. 
 T helper 1 (Th1) lymphocytes are potent inducers of in-
fl ammation. This has been demonstrated by adoptive transfer 
of Th1 lymphocytes in murine models of Th1-associated in-
fl ammatory diseases such as diabetes ( 6 ), infl ammatory bowel 
disease ( 7 ), and rheumatoid arthritis ( 8 ). In these models, the 
induction of infl ammation in a particular tissue by Th1 lym-
phocytes is dependent on restimulation by the cognate anti-
gen in that tissue. Induction of infl ammation by Th1 cells is 
mediated by expression of the proinfl ammatory cytokines 
TNF-  and IFN-  , the latter being a hallmark of Th1 diff er-
entiation. IFN-  also induces expression of the chemokine 
receptor CXCR3 and its ligands CXCL9, -10, and -11, at-
tracting Th1 cells specifi cally to infl amed tissue ( 9 ). Th cells 
with the capacity to recall IFN-  expression, i.e., Th1 mem-
ory cells, are detectable in chronically infl amed tissue ( 10, 11 ). 
The role of Th1 cells in the development and maintenance of 
chronic infl ammation is less clear. Anti – IFN-  therapy has 
been shown to be benefi cial in various Th1-associated in-
fl ammatory diseases ( 12, 13 ). However, a regulatory role for 
IFN-  has also been demonstrated, based on the induction of 
inducible nitric oxide synthase ( 14 ) and of IL-12 in antigen-
presenting cells, in turn increasing the IL-10 synthesis of Th1 
cells ( 15 ). Furthermore, IFN-  inhibits the diff erentiation of 
naive Th cells into proinfl ammatory Th17 cells ( 16, 17 ). 
 In this study, we demonstrate specifi c autoregulation of 
Th1 cells by the transcription factor  twist1 . Expression of 
 twist1 in Th cells is induced by IL-12/STAT4, NF-  B, and 
NFAT, and thus is specifi c for Th1 cells. Th1 eff ector mem-
ory (EM) cells ( 18 ) show increased transient reexpression of 
 twist1 upon T cell receptor engagement.  Twist1 reduces the 
functionality of Th1 cells by attenuating expression of IL-2, 
TNF-  , and IFN-  . Th cells isolated from chronically in-
fl amed gut tissue of patients with ulcerative colitis (UC) or 
Crohn ’ s disease (CD) and synovial fl uid of patients with spon-
dyloarthropathies or rheumatoid arthritis are imprinted to 
express high levels of  twist1 , which indicates a history of re-
peated restimulation and an involvement in the pathogenesis 
of the disease. In murine models of acute and chronic infl am-
mation, i.e., delayed-type hypersensitivity (DTH) and antigen-
induced arthritis, expression of  twist1 by Th1 cells regulates 
Th1-mediated infl ammation. 
 RESULTS 
 Twist1 is transiently expressed in repeatedly activated 
Th1 cells 
 To defi ne transcriptional changes during Th1 memory cell 
diff erentiation, we compared the global gene expression 
of murine Th1 cells, which were activated with antigen 
once or repeatedly at 6-d intervals. Naive CD4 + CD62L hi 
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mouse revealed a conserved STAT binding site at position 
  117 to   137 ( Fig. 3 A ). STAT4 did bind to the proxi-
mal promoter of  twist1 in activated Th1 cells in the pres-
ence of IL-12 as shown by chromatin immunoprecipitation 
(ChIP;  Fig. 2 D ). 
and wild-type Th cells ( Fig. 2 B ). Also, ectopically expressed 
T-bet did not induce  twist1 expression in the absence of IL-12 
in activated Th cells (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20072468/DC1). 
 When CD4 + T lymphocytes of STAT4-defi cient mice were 
stimulated in the presence of IL-12 and IFN-  , no induction 
of  twist1 expression was detectable ( Fig. 2 C ). Phylogenetic 
comparison of the proximal promoter of  twist1 from man and 
 Figure 1.  Twist1 expression is induced in Th1, but not Th2 or Th17 
cells. CD4 + CD62L hi OVA-specifi c T lymphocytes were stimulated in vitro 
under Th1 or Th2, or under Th17-polarizing conditions. Functional polar-
ization of Th1, Th2, and Th17 cells, i.e., the cytokine expression profi le, was 
confi rmed by intracellular immunofl uorescence (Fig. S1). (A)  Twist1 mRNA 
in resting cells 6 d after the last stimulation (Th1; circles) or after 3 h of 
restimulation with anti-CD3/CD28 and IL-2 (Th1; squares) or PMA/iono-
mycin and IL-2 (Th1; triangles: Th2; diamonds) was determined by RT-PCR 
and normalized to hypoxanthine guanine phosphoribosyl transferase 
(HPRT). (B) Kinetics of  twist1 mRNA expression in 6-d-old (open bars) and 
24-d-old (shaded bars) Th1 cells, after stimulation with anti-CD3/CD28 
and IL-2 or IL-2 alone. (C)  Twist1 transcript levels in 6-d-old Th1, Th2, and 
Th17 cells after reactivation with PMA/ionomycin. (D) Twist1 protein ex-
pression in resting (-) and 5 h PMA/ionomycin-restimulated (+) 6- and 
24-d-old Th1 and Th2 cells. Control:   -Tubulin immunoblot (bottom). 
(E) Kinetics of Twist1 protein expression in 24-d-old Th1 cells, before and 
at the indicated time intervals of stimulation with anti-CD3/CD28 and 
IL-2. Data are representative of two experiments. Fig. S1 is available at 
http://www.jem.org/cgi/content/full/jem.20072468/DC1. 
 Figure 2.  Twist1 induction requires IL-12 signaling via STAT4, but 
not IFN-  or T-bet.  (A) CD62L hi DO11.10 Th cells were stimulated for 5 d 
under Th1-polarizing conditions (5 ng/ml IL-12, anti-IL4), reduced IL-12 
(1/25:200 pg/ml; 1/625:8 pg/ml, anti-IL4), in the absence of IL-12 (anti –
 IL-12, anti-IL4), in the presence of IFN-  (10 ng/ml IFN-  , anti-IL-12, 
anti-IL-4), or under Th2-polarizing conditions.  Twist1 mRNA in Th cells 
activated for 3 h with PMA/ionomycin and IL-2 was quantifi ed by RT-PCR. 
The amount of  twist1 transcripts induced under Th1-polarizing conditions 
was set to 1. Data are presented as the mean  ± the SD of at least three 
experiments. (B) CD62L hi Th cells of T-bet   /   mice and syngenic BALB/c 
mice were stimulated with anti-CD3/CD28 and BALB/c APCs under Th1 
(IL-12 and IFN-  ), or under Th2-polarizing conditions for 6 d. Data repre-
sent the mean  ± the SD of three experiments. The amount of  twist1 tran-
scripts induced in activated wt Th1 cells was set to 1. (C) CD4 + cells of 
STAT4   /   and syngenic BALB/c mice were stimulated with anti-CD3/CD28, 
and BALB/c APCs under Th1 (IL-12 and IFN-  ) or under Th2-polarizing 
conditions for 5 d. Data represent the mean  ± SD (four mice each). (D) The 
binding of STAT4 to the proximal promoter of  twist1 was analyzed by 
ChIP. 6-d-old Th1 cells were restimulated with PMA/ionomycin in the 
presence of 10 ng/ml IL-12 for 3 h or left unstimulated. The immuno-
precipitated DNA was quantifi ed by RT-PCR using primers specifi c for the 
proximal  twist1 promoter. The precipitated DNA was normalized to the 
amount of input DNA. The amount of  twist1 transcripts precipitated in 
the presence of IL-12 was set to 1. Data represent the mean  ± SD of three 
experiments. (E) Naive DO11.10 Th cells were stimulated for 5 d with APCs 
and OVA 327-339 under Th1-polarizing conditions. Cells were restimulated 
under the same conditions (Th1), or in the presence of anti – IL-12.  Twist1 
transcripts were quantifi ed on d 11. The amount of  twist1 mRNA on d 5 
was set to 1. Data represent mean  ± SD of three experiments. 
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.org/cgi/content/full/jem.20072468/DC1), but also did not 
induce  twist1 expression in activated Th2 cells, as described 
in  Fig. 1 . 
 IL-12/STAT4 is required for the initial induction of 
 twist1 expression and apparently imprints Th1 cells for 
reexpression of  twist1 upon reactivation by antigen only. 
Upon restimulation of Th1 cells, cells cultured in the ab-
sence of IL-12 showed a 12-fold increase in the expression 
of  twist1 , as compared with a 16-fold increase in the pres-
ence of IL-12 ( Fig. 2 E ). IL-4/STAT6 signaling could not 
suppress  twist1 expression in residual IFN-  – expressing 
cells of Th2 cultures (Fig. S3, available at http://www.jem
 Figure 3.  Signaling through NFAT and NF-  B is required for in-
duction of  twist1 expression. (A) Comparison of the genomic sequence 
of the murine and the human proximal  twist1 promoter (  150 to   100). 
The murine sequence is displayed with conserved bases in capital letters. 
Selected putative DNA-binding motifs are indicated. ISRE, IFN-stimulated 
response element. (B)  Twist1 mRNA in 24-d-old Th1 cells restimulated for 
3 h with PMA/ionomycin and IL-2 in the presence of serial dilutions of the 
NF-  B inhibitor pyrrolidine dithiocarbamate (PDTC; circles; starting con-
centration 50  μ M), the NFAT inhibitor BTP1 (squares; starting concentra-
tion 100 nM), or the NF-  B and NFAT inhibitor cyclosporine A (CsA; 
triangles; starting concentration 30 nM). (C) 24-d-old Th1 cells were re-
stimulated in the presence of IL-2 for 3 h with IL-2 alone (unstimulated) 
or 10 ng/ml TNF-  , PMA, or PMA/ionomycin. The binding of NFAT1 
(D) and the NF-  B subunit p65 (E) to the proximal promoter of  twist1 was 
analyzed by ChIP. 18 – 24-d-old Th1 and Th2 cells either in the resting 
state (-) or after restimulation with PMA/ionomycin and IL-2 for 1 h (+) 
were used. The immunoprecipitated DNA was quantifi ed by RT-PCR using 
primers specifi c for the proximal promoter. The precipitated DNA was 
normalized to the amount of input DNA. The amount of  twist1 transcripts 
precipitated in activated Th1 cells was set to 1. Data represent mean  ± SD 
of 3 experiments. 
 Figure 4.  Ex vivo isolated memory Th cells express  twist1 . Cells 
were sorted by fl ow cytometry and restimulated for 3 h with PMA/iono-
mycin (A – C). (A) Cells were isolated from the spleen and lymph nodes of 
8 – 12-wk-old DO11.10 mice (squares, each representing a pool of 15 indi-
vidual mice) and the pooled inguinal and mesenteric lymph nodes of 4 – 6-
mo-old nephritic MRL/ lpr mice (circles, 1 – 2 mice each). Of note: 90% of 
the CD4 + CD62L hi cells in MRL/ lpr mice represented activated (CD44 + ) 
cells (not depicted). (B)  Twist1 mRNA in peripheral human Th lympho-
cytes. The mean expression of  twist1 mRNA normalized to ubiquitin 
ligase H5 in total CD3 + CD4 + cells was set to 1. Subpopulations were de-
fi ned according to expression of the following surface markers: naive 
(CD4 + CD45RA + CCR7 + ), CM (CD4 + CD45RA - CCR7 + ), EM (CD4 + CD45RA -
 CCR7 - ) with each data point representing one individual healthy donor. 
(C)  Twist1 transcripts in CD3 + CD4 + cells purifi ed from patient material: 
blood (total peripheral CD3 + CD4 + cells from healthy donors, see B), colon 
(noninfl amed colon tissue), UC, and CD (endoscopic biopsies from UC and 
CD patients, respectively), RA, ReA, PsA, and AS (synovial fl uid from rheu-
matoid arthritis, reactive arthritis, psoriatic arthritis, and ankylosing spon-
dylitis patients, respectively) with each dot representing one individual 
patient. Mean  twist1 mRNA expression is displayed from patients who 
were repeatedly sampled. 
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as compared with Th2 cells (Fig. S4, available at http://www
.jem.org/cgi/content/full/jem.20072468/DC1). 
 Th cell – specifi c  twist1 expression in vivo 
 The exclusive expression of  twist1 in Th1 EM cells gener-
ated in vitro is refl ected by the expression pattern of  twist1 
in Th cells isolated ex vivo. Activated CD4 + CD62L hi naive 
and CD4 + CD62L lo memory cells isolated from the spleen 
and lymph nodes of healthy DO11.10 mice, kept under 
specifi c pathogen – free conditions, expressed low levels of 
 twist1 ( Fig. 4 A ). In CD4 + CD62L lo memory Th cells from 
lymph nodes of 4 – 6-mo-old nephritic lupus-prone MRL/
 lpr mice ( 23 )  twist1 mRNA was up-regulated by approx-
imately twofold, as compared with CD4 + CD62L lo Th cells 
from DO11.10 spleen ( Fig. 4 A ).  Twist1 expression was 
enhanced by fi ve- to eightfold in CD3 + B220 + T cells from 
MRL/ lpr mice, which represent chronically activated T lym-
phocytes ( 24, 25 ). 
 In analogy to murine Th lymphocytes, human Th cells 
can express  twist1. Twist1 expression was enhanced by three-
fold in EM (i.e., CD45RA    CCR7    ) Th cells, and eightfold 
in  “ terminally ” diff erentiated CD27    EM Th cells ( 26, 27 ), 
whereas naive (CD45RA + CCR7 + ) and central memory (CM; 
i.e., CD45RA    CCR7 + ) Th lymphocytes expressed less  twist1 
than unseparated Th cells. Activated Th1 EM cells, charac-
terized by the expression of CCR5 ( 28 ), expressed  twist1 , 
whereas Th2 EM cells characterized by expression of chemo-
attractant receptor-homologous molecule expressed on Th2 
cells (CRTh2) ( 29 ) did not ( Fig. 4 B ). 
 Because  twist1 is expressed transiently upon activation 
of Th1 cells, we investigated whether signals from the TCR 
are involved in  twist1 expression control. Phylogenetically 
conserved binding sites for the TCR signal transducers NF-
  B and NFAT are located in the  twist1 promoter at positions 
  104 to   116 and   129 to   140 ( Fig. 3 A ). The NF-  B 
inhibitor pyrrolidine dithiocarbamate ( 20 ), the NFAT-specifi c 
inhibitory 3,5-bistrifl uoromethyl pyrazole derivative BTP1 ( 21 ), 
and the calcineurin-inhibitor cyclosporine A ( 22 ) all blocked 
the PMA/ionomycin-induced expression of  twist1 mRNA 
( Fig. 3 B ), showing that both NFAT and NF-  B are required 
for induction of  twist1 expression in Th1 cells. Accordingly, 
stimulation with either TNF-  or PMA alone, both activating 
NF-  B ( 20 ) but not NFAT, did not induce  twist1 expression, 
whereas PMA in combination with the NFAT-activating iono-
mycin did ( Fig. 3 C ). 
 Using ChIP, the specifi c binding of NFAT1 and the trans-
activating NF-  B subunit p65 to the  twist1 promoter of re-
peatedly stimulated Th1 cells was evident 1 h after reactivation 
( Fig. 3, D–E ). In Th2 cells, no activation-induced binding 
of NFAT1 or NF-  B to the  twist1 promoter was detectable, 
emphasizing that NFAT1 and NF-  B are required, but not 
suffi  cient, to induce transcription of  twist1 in Th cells. For the 
initial expression of  twist1 in Th1 cells, and its imprinting for 
reexpression in further restimulations, the concerted action of 
activated STAT4, NFAT1, and NF-  B is required. Imprint-
ing of the  twist1 gene for reexpression in Th1 cells is refl ected 
by increased acetylation of histone H3 and trimethylated his-
tone H3 at lysine 4, in both resting and reactivated Th1 cells, 
 Figure 5.  Genes differentially expressed upon ectopic  twist1 overexpression. Splenic DO11.10 cells were activated in vitro with the cognate pep-
tide OVA 327-339 in the presence of 1 ng/ml IL-12 and 1 ng/ml IL-2. On d 2, cells were infected with control retrovirus, or  twist1- encoding virus. On d 5, cells 
were sorted according to expression of the viral marker gene  gfp . Cells were restimulated for 4 h with PMA/ionomycin. The transcriptional profi les of 
duplicates of cultures were compared. 
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expressed  twist1 transcript levels lower than the reference value 
of total peripheral Th cells (unpublished data). 
 Functional modulation of Th1 cells by  twist1 
 We analyzed the impact of  twist1 on the function of Th1 EM 
cells by ectopic overexpression of  twist1 in murine DO11.10 
Th cells. A global view of  twist1 -induced modulation of gene 
expression in Th1 cells is provided in  Fig. 5 . Of the 14,000 
genes analyzed for transcription, 58 were diff erentially expressed 
by a factor of 1.5 or more when comparing activated Th1 cells 
that express  twist1 ectopically and those that do not ( Fig. 5 ). 
These genes fall into 4 groups, with respect to their presump-
tive function: 17 genes are involved in cell activation and apop-
tosis, 11 genes are involved in cell adhesion and motility, 13 
genes relate to the chemokine/cytokine repertoire of Th1 cells, 
and 17 genes are of metabolic or undefi ned relevance. 
 Of relevance for the eff ector function of Th1 EM cells,  twist1 
attenuated expression of the eff ector cytokine genes  il-2, ifn-  , 
and  tnf-  by a factor of up to 1.6 ( Fig. 5 and Table S3, available 
at http://www.jem.org/cgi/content/full/jem.20072468/DC1). 
The moderate reduction of mRNA levels of eff ector cyto-
kines had a drastic eff ect on protein expression regardless of the 
direction of Th cell diff erentiation. Ectopic  twist1 expression 
reduced the frequencies of cytokine-expressing reactivated 
Th1 or Th2, or of Th cells that had been stimulated without 
addition of polarizing cytokines to the culture, to 40 – 50% of 
the controls ( Fig. 6 and Fig. S5). 
 The molecular basis of the regulation of cytokine gene 
expression by  twist1 could be either direct inhibition of 
NF-  B, as has been shown for COS cells ( 4 ), or binding of 
Twist1 to E-boxes of regulatory elements of the cytokine 
genes, blocking activating transcription factors, as has been 
shown for primary macrophages ( 5 ). Here, we show that ec-
topic  twist1 expression in activated Th cells cannot inhibit 
activation-induced transcription of an NF-  B – reporter con-
struct lacking E-boxes, i.e., Twist1 does not inhibit NF-  B 
directly ( Fig. 7 A ), in contrast to the constitutively active mu-
tant form of  inhibitor of NF-  B ( I-  B  M ), in an experimental 
situation where both Twist1 and I-  B  M are expressed at 
similar levels (Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20072468/DC1), and both attenuate the 
expression of endogenous cytokine genes to the same degree 
( Fig. 7 B ). This result implies that  twist1 regulates gene ex-
pression of Th1 cells by binding to E-boxes of specifi c target 
genes, and not the entirety of NF-  B – regulated genes. NF-  B 
signaling for the generation and survival of Th1 memory 
cells ( 30, 31 ) is not inhibited by  twist1 , as is also evident from 
the high  twist1 expression of repeatedly restimulated Th1 
cells ( Fig. 1 ). 
 Twist1 regulates Th1-mediated infl ammation 
 In a murine transfer model of OVA-specifi c DTH, the eff ect 
of  twist1 expression on the infl ammation induced by trans-
ferred Th1 cells was analyzed. OVA-specifi c 6-d-old Th1 
cells ectopically overexpressing  twist1 and control Th1 cells 
were transferred intravenously into naive BALB/c mice. 
 Th cells isolated from infl amed tissue of patients with 
chronic infl ammatory diseases are imprinted for high  twist1 
expression. Although highly variable,  twist1 transcripts were 
increased by up to 400-fold, as compared with peripheral Th 
cells, in CD3 + CD4 + cells isolated from the synovial fl uid of in-
fl amed joints of patients with rheumatoid arthritis or spondylo-
arthropathies, and in Th cells isolated from mucosal endoscopic 
biopsies and surgical specimens of patients suff ering from CD 
or UC ( Fig. 4 C and Table S2, available at http://www.jem
.org/cgi/content/full/jem.20072468/DC1).  Twist1 mRNA 
expression in repeatedly sampled patients with persistent in-
fl ammation of colon or synovia remained in the same range 
over up to 18 mo (Table S2). Among T cells isolated from the 
infl amed tissue, only CD4 + Th cells showed enhanced  twist1 
expression. CD3 + CD4    cells, i.e., cytotoxic (Tc) lymphocytes, 
 Figure 6.  Twist1 suppresses the expression of effector cytokines. 
DO11.10 Th cells were stimulated for 5 d under Th1- or Th2-polarizing 
conditions or without addition of cytokines. On d 2, cells were infected 
with control virus or  twist1 -encoding virus. The cells were restimulated 
on d 6 and stained for intracellular cytokine expression. (A) Representative 
histograms of cytokine expression in Th cells ectopically expressing  twist1 
(black line) and control cells (gray fi lled). The cells displayed were gated 
for expression of CD4 and the viral marker gene  gfp . (B) Frequencies of 
cytokine-expressing cells among infected, i.e., GFP + CD4 + T cells relative to 
the noninfected CD4 + cells. Cells had been stimulated without addition 
of cytokines and infected with control virus (open bars) or  twist1 -encod-
ing virus (fi lled bars). Data represent the mean  ± SD of four indepen-
dent experiments. 
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ized OVA into the knee joint, and histological analysis was 
performed 3 wk after induction of arthritis, i.e., in the chronic 
phase of infl ammation.  Twist1 knockdown and control Th1 
cells equally homed to and persisted in the spleen and mesen-
teric and draining lymph nodes ( Fig. 9, C – E ). However,  twist1 
knockdown in Th1 cells resulted in a signifi cantly higher his-
tological score of infl ammation and tissue destruction ( Fig. 9 F 
and Table S4, available at http://www.jem.org/cgi/content/
full/jem.20072468/DC1). In particular, infi ltration of granu-
locytes and mononuclear cells into the infl amed tissue of the 
knee joint was drastically enhanced ( Fig. 10 and Fig. S8), as 
were characteristics of chronic infl ammation, i.e., prominent 
hyperplasia of the lining cells, pannus formation, increased 
vascularization, and hyperplasia of synovial fi broblasts in the 
sublining layer ( Fig. 10 and Fig. S8). Increased numbers of 
Gr-1 + granulocytes at the surface of the synovium and focal 
accumulation of F4/80 + macrophages were observed after 
transfer of  twist1 knockdown Th1 cells as compared with con-
trol Th1 cells (Fig. S8). Anti-TNF-  staining of joint sections 
revealed stronger TNF-  expression, especially in the lining 
cells and the sublining layer after transfer of Th1 cells express-
ing a  twist1 -targeting shRNA ( Fig. 10 ). Presumably as an ad-
ditional consequence of the higher infl ammation in the mice 
receiving  twist1 knockdown Th1 cells, more CD3 + T cells 
were found in the infl amed joints ( Fig. 10 ). 
 DISCUSSION 
 Control of infl ammation critically depends on the  twist genes. 
Genetic haploinsuffi  ciency of both  twist1 and  twist2 results in 
fatal systemic infl ammatory immunopathology in mice, which 
die before day 14 ( 4 ). In this study, we show that  twist1 is ex-
pressed in Th1 EM cells. Its expression is induced by IL-12 
After 1 d, OVA 323-339 emulsifi ed in IFA was injected into one 
footpad and the swelling of this footpad was monitored. Th1 
cells overexpressing  twist1 showed a signifi cantly (P  < 0.05) 
reduced induction of footpad swelling, starting from day 4 to 
7, when compared with control Th1 cells ( Fig. 8 A ). For 
DTH mediated by Th1 cells the proinfl ammatory role of 
Th1-derived cytokines such as IFN-  has been shown ( 32 ). 
Transferred Th cells overexpressing  twist1 , when reisolated 
from the draining lymph nodes of the host, expressed four-
fold reduced levels of IFN-  mRNA as compared with the 
control cells ( Fig. 8 B ). Homing of transferred Th1 cell pop-
ulations to the infl amed tissue and the draining lymph nodes 
was not aff ected by  twist1 overexpression, as shown by the 
transfer of radiolabeled cells ( Fig. 8 C ). The accumulation of 
ectopically  twist1- expressing Th1 cells in the draining lymph 
nodes and the infl amed foot pads, as well as in other organs 
(Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20072468/DC1), was comparable to that of transferred 
control Th1 cells. 
 Autoregulation of Th1-mediated infl ammation by  twist1 
was also analyzed in a murine adoptive transfer model of antigen-
induced arthritis ( Fig. 9 A ). In this model, we used the com-
plementary genetic approach to knockdown  twist1 expression 
in Th1 cells by RNA interference. Murine DO11.10 Th1 
cells generated in vitro were infected with a retrovirus encod-
ing a small hairpin RNA (shRNA) targeting  twist1 ( 3 ) or a 
corresponding scrambled control shRNA.  Twist1 -specifi c 
shRNA reduced the level of activation-induced endogenous 
 twist1 transcripts in Th1 cells to   30% of the control value 
( Fig. 9 B ). Two-time restimulated Th1 cells expressing those 
shRNAs were intravenously injected into SCID mice. 1 d af-
ter cell transfer, arthritis was induced by injection of cation-
 Figure 7.  Inhibition of NF-  B – mediated signaling by  twist1 is promoter-specifi c. DO11.10 Th cells were stimulated with OVA 327-339 , APCs, and 
1 ng/ml IL-12. On d 2, cells were infected with control virus,  twist1, or I-  B  M-encoding virus. On d 3, cells were nucleoporated with a mixture of a plas-
mid encoding  Renilla luciferase , and a  fi refl y luciferase reporter construct, driven by a NF-  B – responsive promoter (4x  B-luc). (A) Cells were restimulated 
with PMA/ionomycin for 6 h, sorted according to expression of the viral marker gene  gfp , and luciferase signals were quantifi ed in duplicates (mean  ± 
SD). (B) The very same Th1 cultures were restimulated on d 5 and stained for intracellular cytokine expression. Frequencies of cytokine-expressing cells 
among infected, i.e., GFP + CD4 + T cells, are displayed. Data are representative of two experiments. 
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only in the original stimulation, to imprint the gene for reex-
pression. This imprinting is evident from the increased re-
expression upon stimulation with TCR signals alone, in the 
absence of IL-12, and it is refl ected in the acetylation and tri-
methylation of H3 histones at the  twist1 promoter region, as 
is shown here. The requirement of NFAT for induction of 
 twist1 expression in Th1 cells distinguishes control of  twist1 
expression in Th cells from its control in fi broblasts, where 
TNF-  – induced activation of NF-  B is suffi  cient to induce 
expression ( 4 ). In activated macrophages, type I IFNs induce 
the expression of  twist1 ( 5 ), and they express both  twist genes, 
i.e.,  twist1 and  twist2 , whereas activated Th1 cells exclu-
sively express  twist1. In Th lymphocytes,  twist1 expression is 
not induced by type I IFNs. Addition of IFN-  during the 
primary activation of Th cells in the absence of IL-12 did 
not suffi  ce to induce  twist1 expression (Fig. S9, available at 
http://www.jem.org/cgi/content/full/jem.20072468/DC1). 
via STAT4 and TCR signaling, activating NFAT and NF-  B. 
Expression of  twist1 follows TCR stimulation transiently 
and increases upon repeated stimulation. Thus, imprinting 
for enhanced  twist1 expression is a hallmark of repeatedly re-
stimulated Th1 memory cells. 
 The proximal promoter of  twist1 contains phylogeneti-
cally conserved binding sites for NFAT, NF-  B, and STAT 
proteins. Both NFAT and NF-  B have to bind to the pro-
moter of  twist1 in Th cells to induce expression, i.e.,  twist1 is 
expressed only by activated Th cells. In the initial activation 
of naive Th cells, NFAT and NF-  B cannot induce tran-
scription of  twist1 on their own, but require concerted bind-
ing of activated STAT4 to the promoter of  twist1 . Of all 
costimulatory signals involved in the lineage diff erentiation 
of murine Th1, Th2, or Th17 cells, only IL-12 was able to 
induce transcription of  twist1 . Neither IL-4, in Th2 polarization, 
nor IL-6, TGF-  , and IL-23 in Th17 polarization, could in-
duce expression of  twist1 . Of the Th1-polarizing signals, IL-
12/STAT4, but not IFN-  /STAT1, is required to induce 
 twist1 expression. T-bet is not involved. STAT4 is required 
 Figure 8.  Ectopic  twist1 overexpression controls DTH. (A) Naive 
DO11.10 Th cells were stimulated under Th1-polarizing conditions. On d 2, 
cells were infected with control virus (circles) or  twist1 -encoding virus 
(squares). On d 6, infected GFP + cells were injected i.v. into BALB/c mice. 
The DTH response was induced by s.c. OVA 323-339 /IFA injection into the left 
footpad (fi lled symbols), and   footpad thickness (mean  ± SD;  n = 4, 
Mann-Whitney test, nonparametric) was determined thereafter. Injection 
of PBS/IFA served as control (open symbols). (B) Ex vivo IFN-  mRNA ex-
pression in transferred GFP + Th1 cells 24 h after DTH induction isolated 
from the draining popliteal lymph node (left foot). (C) To monitor the 
migratory capacity of the transferred cell populations, infected GFP + Th 
cells were radiolabeled and injected i.v. into BALB/c mice 1 d after induc-
tion of the DTH response. 24 h later radioactivity recovered from indicated 
tissues was determined using a   -counter (mean  ± SD;  n = 4). 
 Figure 9.  Twist1 knockdown increases infl ammatory response in 
murine arthritis. (A) Experimental scheme. (B)  Twist1 mRNA in 18-d-old 
Th1 expressing  twist1 -targeting shRNA or control shRNA restimulated 
with PMA/ionomycin. (C – E) Cell numbers of adoptively transferred GFP + 
Th cells in spleen, mesenteric lymph nodes, and draining lymph nodes 
were analyzed on d 21 using FlowCount Beads. (F) Transfer of Th1 cells 
expressing a  twist1 -targeting shRNA leads to a signifi cantly higher histo-
logical score in murine arthritis compared with control Th1 cells (d 21). 
Data are representative of two experiments. 
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to a subset of memory cells. Among murine CD4 + CD62L lo 
memory-phenotype Th cells that were isolated from spleen 
or lymph nodes of naive DO11.10 mice, expression of  twist1 
is low. In CD3 + B220 + T cells isolated from nephritic MRL/
 lpr mice, which represent chronically activated T cells ( 24, 25 ), 
 twist1 expression is up-regulated fi ve- to eightfold compared 
with DO11.10 memory-phenotype Th cells. This is moderate 
when compared with the   20-fold up-regulation upon re-
peated restimulation of Th1 cells observed in vitro, and may 
refl ect the heterogeneous composition of the cell populations 
analyzed. As expected from the phylogenetic conservation of 
the  twist1 promoter,  twist1 is also expressed by activated human 
Th cells. It is low in peripheral human naive Th cells and in 
CCR7 + CM Th cells.  Twist1 expression is enhanced in 
CCR7    EM Th cells, in particular in the  “ terminally diff er-
entiated ” CCR7    CD27    EM cells ( 26, 27 ). Among CCR7    
EM cells,  twist1 is expressed less by CRTh2 + Th cells, which 
have been shown to be mostly Th2 cells ( 29 ). CCR7    CCR5 + 
EM cells, which contain Th1 EM and Th17 EM cells ( 33 ) 
have up-regulated activation-induced expression of  twist1 , as 
we show here. Because at least Th17 cells generated in vitro 
do not express  twist1 , the expression in CCR7    CCR5 + Th 
EM cells is probably caused by Th1 EM cells. Thus, the pheno-
type of human peripheral  twist1 -expressing Th cells is that of 
repeatedly restimulated Th1 EM cells. Remarkably, expression 
of  twist1 is highly up-regulated in CD3 + CD4 + T cells isolated 
from infl amed tissues of patients with chronic infl ammation 
of joints or gut. Repeated biopsies from individual patients 
show persistent  twist1 mRNA levels over time, i.e., the per-
sistence of chronically reactivated Th1 cells, despite state-of-
the-art therapeutic treatment. Their imprinting for increased 
 twist1 expression, maintained over time in individual patients, 
indicates a history of repeated restimulation and an endogenous 
regulation of proinfl ammatory eff ector functions under the 
control of NFAT and NF-  B. 
 Twist1 itself is a transcriptional repressor binding to E-
boxes in the regulatory regions of target genes ( 34 ). For COS 
cells, it has been shown that ectopically expressed  twist1 can 
interact directly with the p65 subunit of NF-  B and inhibit 
its function ( 4 ). In contrast, for primary murine macrophages, 
 twist1 has been shown to block transcription of target genes 
by binding to E-boxes within the promoter ( 5 ). In this study, 
we show that in Th1 cells,  twist1 cannot block NF-  B – driven 
transcription of a reporter gene construct that lacks E-boxes 
in the promoter, suggesting that  twist1 acts through binding 
to E-boxes, as in macrophages. In accordance, ectopically ex-
pressed  twist1 only regulates the expression of a restricted set 
of 58 genes in 1-wk-old Th1 cells by a factor of at least 1.5. 
Expression of 29 genes is up-regulated, and that of another 
29 genes down-regulated. Apart from several genes of un-
known and metabolic function, these genes are involved in 
survival, eff ector function, and motility of the cells. With re-
spect to cytokine expression,  twist1 reduces activation-induced 
expression of TNF-  , IL-2, and IFN-  by Th1 memory cells 
by  > 50% at the protein level. Apart from cytokine expression, 
 twist1 also decreases expression of proinfl ammatory chemokines 
These fi ndings provide evidence that expression of the anti-
infl ammatory  twist genes is controlled by type I IFNs and 
TNF-  in fi broblasts and macrophages in innate immune re-
sponses ( 4, 5 ), and is controlled by antigen and IL-12 in Th 
cells in adaptive immune responses; i.e.,  twist expression is 
induced by those cytokines controlling the induction of in-
fl ammatory immune responses. 
 In this study, we have identifi ed  twist1 as a gene that is 
diff erentially expressed by Th1 cells versus Th2 cells, com-
paring the transcriptomes of once and repeatedly restimulated 
murine Th1 and Th2 cells generated in vitro from bona fi de 
naive Th cells. Expression of  twist1 increases upon repeated 
restimulation in vitro in Th1 cells, whereas it is not induced 
even in repeatedly restimulated Th2 or Th17 cells. Accord-
ingly, in Th cells isolated ex vivo, twist1 expression is restricted 
 Figure 10.  Twist1 knockdown leads to pronounced signs of chronic 
infl ammation in murine arthritis. Representative hematoxylin/eosin 
staining of knee joint sections (d 21) showing hyperplasia of the lining 
cells and the subintimal layer with pannus formation (bar, 200  μ m), more 
pronounced infi ltration of CD3 + T cells (magnifi cation of boxed areas in 
top row; bar, 100  μ m) and stronger expression of TNF-  (red) especially of 
the enlarged lining and sublining layer (magnifi cation of boxed areas in 
second row; bar, 50  μ m) after transfer of Th1 cells expressing a  twist1 -
targeting shRNA as compared with the control group. Data are represen-
tative of fi ve mice each. 
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Th cells, by means of either addressing  twist1 or a gene regu-
lated by it, seems more promising, because it is more specifi c 
for repeatedly restimulated Th1 memory cells involved in 
chronic infl ammation. It remains to be shown whether these 
cells in chronic infl ammatory diseases are the critical Th cells 
capable of driving infl ammation, as we show in this study for 
the experimental model of antigen-induced arthritis. 
 MATERIALS AND METHODS 
 Mice and reagents.  MRL lpr/lpr , BALB/c, C57BL/6, SCID, STAT4-defi -
cient mice (Stat4 tm1Gr ), and OVA-TCR tg/tg DO11.10 mice were purchased 
from The Jackson Laboratory or were bred under specifi c pathogen – free 
conditions in our animal facility. T-bet – defi cient mice were a gift from 
J. Penninger (Institute for Molecular Biotechnology of the Austria Academy 
of Sciences, Vienna, Austria). All animal experiments were performed in 
accordance with institutional, state, and federal guidelines (Landesamt F ü r 
Gesundheit und Soziales, Berlin, Germany). Reagents were purchased from 
Sigma-Aldrich unless otherwise stated. BTP1 was synthesized by M. Paetzel 
(Humboldt University of Berlin, Berlin, Germany). Cyclosporin A was pur-
chased from Calbiochem. 
 Patients.  Endoscopic mucosal and surgical mucosal specimens were ob-
tained from UC ( n = 9) and CD ( n = 7) patients. UC and CD were diag-
nosed according to established clinical, endoscopic, radiological, and 
pathological criteria. All UC and CD patients displayed moderately to se-
verely active disease according to the Truelove and Witts Severity Index ( 41 ) 
and the Harvey Bradshaw Severity Index ( 42 ), respectively. Control samples 
were obtained from patients ( n = 4) undergoing colonectomy because of 
colon cancer. Mucosal control specimens used in the study were from the 
macroscopically noninvolved tissue distant from any detectable lesion. Syno-
vial fl uid was obtained from patients suff ering from rheumatic diseases who 
had active synovitis with eff usion. Patients with rheumatoid arthritis (RA; 
 n = 4) fulfi lled the American College of Rheumatology 1987 classifi cation 
criteria for RA, patients with ankylosing spondylitis (AS;  n = 5) fulfi lled 
the modifi ed New York criteria (1984), and patients with psoriatic arthritis 
( n = 3) or reactive arthritis ( n = 3) fulfi lled the European Spondyloar-
thropathy Study Group (ESSG) criteria for SpA. Clinical characteristics 
of the patients are listed in Table S2. All experiments were approved by the 
local ethics committee (Charite Ethikkommision), and all patients gave in-
formed consent. 
 Isolation of human lymphocytes.  PBMCs from buff y coats from healthy 
donors, and synovial fl uid mononuclear cells were isolated by density gradi-
ent centrifugation (Lymphocyte separation medium; PAA). Pooled intraepi-
thelial leukocytes and lamina propria leukocytes were obtained from mucosal 
specimens by treatment with collagenase type IV, followed by passage 
through a sieve. Mononuclear cells were collected from the 40 – 70% inter-
phase of a discontinuous percoll (Pharmacia) gradient. 
 Flow cytometry.  The following antibodies directed against murine anti-
gens were either purifi ed from hybridoma supernatants and conjugated in-
house or purchased as indicated: anti-CD3 (145-2C11), anti-CD4 (GK1.5), 
anti-CD8 (53 – 6.7), anti-CD11c (N418), anti-CD44 (IM7), anti-CD62L 
(MEL14), anti-DO11.10 OVA-TCR (KJ1.26), anti-B220 (RA3.6B2), anti-
IL2 (JES6-5H4; Caltag Laboratories), anti-IL-4 (11B11; BD Biosciences), 
anti-IFN-  (AN18.17.24), and anti-TNF-  (MP6-XT22; Caltag). Anti-
bodies recognizing human antigens were obtained from BD Biosciences 
unless stated otherwise: anti-CD3 (OKT3; in-house conjugate), anti-CD4 
(TT1; in-house conjugate), anti-CD27 (L128), anti-CD45RA (HI100), 
anti-CRTh2 (BM16), and anti-CCR5 (2D7/CCR5). Cells were counted 
by using FlowCount Beads (Beckman Coulter). Cytometric analysis was 
performed with FACSCalibur using CellQuest (BD Biosciences) and FCS 
Express (De Novo) software. Cells were separated by fl uorescence-activated 
cell sorting (FACSAria and FACSDiva; BD Biosciences). 
and chemokine receptors, and attenuates cytokine recep-
tor signaling by up-regulating SOCS-1 and -2, the IL-1 decoy 
receptor, and by down-regulating Jak2, the kinase involved 
in IL-12 signaling.  Twist1 in Th1 cells thus acts as an endog-
enous regulator limiting the proinfl ammatory potential of 
Th1 cells in the continuous presence of antigen, i.e., repeated 
activation of NFAT and NF-  B. 
 The key role of  twist1 expression by Th1 cells for the self-
limitation of Th1-induced infl ammation is evident from the 
present analysis of murine models of infl ammation. Ectopic 
overexpression of  twist1 in 6-d-old Th1 cells, which still 
had a low endogenous expression level, drastically reduced 
their pathogenic contribution to DTH. Conversely, shRNA-
mediated knockdown of  twist1 in Th1 cells signifi cantly en-
hanced their potential to induce chronic infl ammation in 
a murine model of antigen-induced arthritis. In this model, 
OVA-specifi c Th1 cells, when adoptively transferred into 
SCID mice and challenged by intraarticular OVA, induce a 
chronic infl ammation of the joint. Adoptive transfer of Th1 
cells versus Th1 cells with a shRNA-mediated knockdown 
of  twist1 expression demonstrates the relevance of  twist1 ex-
pression by Th1 cells for the control of immunopathology. 
When analyzed on day 21 after transfer, mice with a knock-
down of  twist1 expression in Th1 cells showed increased hy-
perplasia of the lining cells and synovial fi broblasts in the 
sublining layer, pannus formation, and vascularization. Num-
bers of Gr-1 + granulocytes and F4/80 + macrophages, as well 
as TNF-  expression of lining and sublining cells, were in-
creased in the Th1  twist1 knockdown situation. 
 Why is expression of  twist1 up-regulated gradually? One 
explanation might be that a regulatory gene is not expressed in 
initial Th1 activations, to allow full initial reactivity of the Th1 
cells. Accordingly, ectopic  twist1 expression in Th1 cells right 
from the beginning impairs their function in acute infl amma-
tion of DTH. In repeated restimulations, refl ecting a lack of 
clearance of the antigen and increased risk of immunopathol-
ogy, regulation of Th1 may help to limit immunopathology, 
as we show in the chronic infl ammation of the antigen-
induced arthritis model by knockdown of  twist1 , but  twist1 -
expressing Th1 cells are still capable of driving infl ammation. 
 Apart from its role in limiting immunopathology in chronic 
infl ammation,  twist1 and the genes controlled by it could be 
regarded as biomarkers for pathogenic EM cells.  Twist1 is not 
imprinted for enhanced expression in naive and CM CCR7 + 
Th cells. Even CCR7    CCR5 + Th1 EM cells will only ex-
press a low level of  twist1 upon restimulation compared with 
Th cells from chronically infl amed tissue. Initial clinical stud-
ies aiming at a complete depletion of CD4 + T lymphocytes 
in patients with chronic infl ammatory diseases suggested a 
clinical benefi t, but the studies had to be terminated because 
of the severe side eff ects of systemic depletion of Th lympho-
cytes ( 35 – 37 ). Targeting of CD4- and CD3-expressing cells 
with nondepleting antibodies and neutralization of Th-re-
lated eff ector cytokines have demonstrated clinical effi  cacy 
( 12, 13, 15, 38 – 40 ), but all of them impair protective as well 
as pathogenic T cell memory. Targeting of  twist1 -expressing 
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or F4/80 (eBioscience). For detection biotinylated donkey anti – rat or donkey 
anti – goat (Dianova) secondary antibodies were used followed by the streptav-
idin AP kit (K5005; Dako). Or sections were incubated with goat anti-TNF-  
antibody followed by Alexa Fluor 555-conjugated anti – goat antibody (Invit-
rogen) and incubated with rabbit polyclonal anti-CD3 followed by Alexa 
Fluor 488 – conjugated anti – rabbit antibody (Invitrogen). Nuclei were coun-
terstained with DAPI (Roche), and slides were mounted in Fluoromount-G 
(SouthernBiotech). Images were acquired using a fl uorescence microscope 
(AxioImager Z1) equipped with a charge-coupled device camera (AxioCam 
MRm) and processed with Axiovision software (Carl Zeiss, Inc.). 
 Immunoblot.  Immunoblot was performed with a monoclonal Twist-spe-
cifi c antibody (  TwiMab-1) ( 45 ) conjugated in-house to digoxygenin 
(Roche Diagnostics), anti – tubulin-  (DM1A; Calbiochem), anti-T-bet 
(4B10; Santa Cruz Biotechnology, Inc.), or anti-I  B  (Cell Signaling Tech-
nology), followed by incubation with horseradish peroxidase – coupled anti-
digoxigenin FAB-fragments (Roche) or anti – mouse or anti – rabbit (Santa 
Cruz Biotechnology, Inc.) secondary antibodies. Individual bands were vi-
sualized with enhanced chemiluminescence (GE Healthcare) and the Intelli-
gent Dark Box System LAS-3000 (Fujifi lm). 
 Retroviral expression vectors and retroviral infection.  The  twist1 -tar-
geting shRNA vector was generated by amplifi cation of the EF1  -promotor 
and GFP from pLVTHM, provided by D. Trono (Ecole Polytechnique 
F é d é rale de Lausanne, Lausanne, Switzerland) followed ligation into pQCXIX 
(Clontech Laboratories, Inc.) with XbaI and EcoRV. The  twist1 target sequence 
corresponds to Twist-siRNA3 (5  -AAGCTGAGCAAGATTCAGACC-3  ), 
as published by Yang et al. ( 3 ). A corresponding scrambled sequence was 
used as control. The DNA oligonucleotides were subcloned using HpaI and 
XhoI into pLL3.7, which was provided by L. Van Parijs (Massachusetts 
Institute of Technology, Cambridge, MA). The fragment containing the 
murine U6-promotor and the shRNA-encoding sequence was amplifi ed by 
PCR, introducing an additional 5  -XhoI site and ligated into the SalI site of 
pQXIX- gfp located in the inactivated 3  -LTR. For retroviral overexpression 
the vector GFP-RV ( 46 ) was used, provided by K.M. Murphy (Howard 
Hughes Medical Institute, St. Louis, Missouri). Murine  t-bet (cDNA gener-
ated from Th1-cells), murine  twist1 (IMAGE cDNA clone; AccessionID: 
BC033434-NCBI), and constitutively active I  B  M (pCMV-I  B  M; 
Clontech Laboratories, Inc.) were amplifi ed, introducing BglII- and XhoI-
compatible restriction sites and ligated into the vector upstream of the inter-
nal ribosome entry site- gfp cassette. Sequences of primers and oligonucleotides 
for shRNA expression are listed in Table S5. Retroviral stocks were obtained 
by calcium phosphate cotransfection of HEK293 cells with the retrovirus 
packaging plasmids pECO and pCGP. The medium was replaced after 4 h, 
and viral supernatants were collected 24 – 48 h later. Th cells were infected 
40 h after activation by 60 min centrifugation at 700 g at 30 ° C with viral 
 supernatant and 8  μ g/ml polybrene, followed by replacement of the viral 
 supernatant with the former culture supernatant. 
 Luciferase reporter assay.  NF-  B activity was monitored using the pNF-
  B-Luc vector (Clontech Laboratories, Inc.). Transfection effi  ciency was 
controlled by cotransfecting pRL-TK (Promega). Murine T cells were elec-
troporated with the reporter constructs using Mouse T cell kit (AMAXA) 
and Nucleofector I (AMAXA). Luciferase activity was quantifi ed with Dual 
Luciferase Assay kit (Promega) and a luminometer (Moonlight 3096; BD 
Biosciences). 
 Microarray experiments.  Total RNA was extracted using Trizol reagent 
(Invitrogen), 10  μ g was reverse-transcribed, followed by cDNA extraction 
with a PhaseLock gel (Eppendorf), and precipitated with ethanol and ammo-
nium acetate. Biotinylated cRNA was transcribed with the MEGAscript 
high-yield transcription kit (Ambion), fragmented, and the hybridization 
cocktail was prepared according to Aff ymetrix protocols (15  μ g fragmented 
biotin-labeled cRNA spiked with Eukaryotic Hybridization control). The 
 Cell culture.  Naive CD4 + CD62L + lymphocytes from 6 – 8-wk-old DO11.10 
mice were isolated and polarized under Th1 or Th2 conditions, as previously 
described ( 15 ). Irradiated (30 Gy) BALB/c splenocytes were used as APCs at 
a ratio of 5:1 and the cognate peptide OVA 323-339 (provided by R. Volkmer-
Engert, Humboldt University of Berlin, Berlin, Germany) was added at 0.5  μ M. 
Alternatively, plates were coated with 3  μ g/ml anti-CD3 (145-2C11) in 
PBS, and CD4 + cells were plated at a density of 2  × 10 6 cells/ml in medium 
plus 1  μ g/ml soluble anti-CD28 (37.51). For Th17 diff erentiation, cells were 
stimulated in the presence of 1 ng/ml TGF-  (R & D Systems), 20 ng/ml 
IL-6 (R & D Systems), and 20 ng/ml IL-23 (R & D Systems), as well as 10  μ g/ml 
anti-IL-4 and 10  μ g/ml anti – IFN-  . Irradiated IL-12 p35   /   splenocytes 
were used as APCs. Every 6 d, viable Th cells were harvested and restimu-
lated under the original conditions, except that 10 ng/ml murine IL-2 (R & D 
Systems) was added to the Th1 and Th2 cultures. 
 Mitogenic restimulation and intracellular cytokine staining.  Cells 
were restimulated with 10 ng/ml PMA, and 1  μ g/ml ionomycin or with 
plate-bound anti-CD3 (10  μ g/ml), and soluble anti-CD28 (1  μ g/ml). For 
restimulation of murine T cells, 10 ng/ml IL-2 was added. For intracellular 
staining of cytokines, T cells were stimulated for 2 h with PMA/ionomycin 
and an additional 3 h with 5  μ g/ml of brefeldin A. Cells were fi xed with 2% 
formaldehyde in PBS for 15 min at room temperature and permeabilized 
with 0.5% wt/vol saponin. 
 ChIP.  ChIP was performed as previously described ( 15 ) using anti-NFAT1 
(AB1-209; ImmunoGlobe Antikoerpertechnik), anti-p65 (C-20; Santa Cruz 
Biotechnology, Inc.), anti-STAT4 (C-20; Santa Cruz Biotechnology, Inc.), 
anti – acetyl-histone 3 (#06 – 599; Millipore) or anti – trimethyl-K4-histone 3 
(#07 – 473; Millipore), followed by incubation with Protein A micro-
beads. The relative amount of precipitated DNA was calculated with 
E  Δ Cp  (input - immunoprecipitate) . The following primers were used to amplify the proxi-
mal  twist1 promoter: (  150 forward) 5  -GGGCTGGAAAGAGGAAACTT-
3  ; (+4 reverse) 5  -CGCGAGGTGTCTGAGAGTT-3  . 
 Th1-mediated DTH model.  The OVA-specifi c DTH model was per-
formed as described elsewhere ( 43 ). In brief, 5  × 10 5 Th1 cells were injected 
i.v. into BALB/c mice, and 24 h later, the DTH response was induced by 
s.c. injection of 250 ng OVA 323-339 /IFA into the left footpad. PBS/IFA, in-
jected into the right footpad, served as a control. The footpad thickness 
measured before the injection of the antigen was subtracted from the footpad 
thickness measured during the DTH response. The homing of adoptively 
transferred Th1 cells was performed as previously described ( 44 ). In brief, Th 
cells were labeled with  51 Chromium (Amersham Buchler) at 37 ° C (2  × 10 7 
cells/ml; 20  μ Ci/ml) in fresh medium. Removal of dead cells was done by 
gradient centrifugation (17.1% isotonic Nycodenz). Labeled cells were co-
adoptively transferred into recipient animals at 1 d after the DTH induction. 
24 h later, indicated tissues were removed and diff erential measurement of 
recovered radioactivity was done on a   counter (Wallac Counter). 
 Antigen-induced arthritis.  2  × 10 6 12-d-old GFP + Th1 cells were trans-
ferred i.v. into naive SCID mice. 1 d later, arthritis was induced by intraar-
ticular injection of 60  μ g cationized OVA into one knee joint. The 
contralateral knee joint was left untreated. 21 d later, mice were killed and 
knee joints were fi xed in 10% formaldehyde, decalcifi ed in saturated EDTA 
solution, and embedded in paraffi  n. Knee joint sections were stained with 
hematoxylin/eosin and scored for exudates, granulocyte infi ltration, hyper-
plasia, fi broblast proliferation/mononuclear cell infi ltration, periarticular 
mononuclear cell infi ltration (each scoring 0 – 3), bone/cartilage destruction 
(scoring 0 – 4), and an additional score of 1 for visible fi brin deposition and 
periarticular granulocyte infi ltration, resulting in a maximum score of 21. 
 Immunohistochemistry.  Formalin-fi xed paraffi  n-embedded tissue was 
subjected to a heat-induced epitope retrieval step and stained with anti-CD3 
(#N1580; Dako), TNF-  (PeproTech), anti-Gr-1 (RB6-8C5; eBioscience), 
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 Figure S1. Representative cytokine profiles of ex vivo–polarized Th1, Th2, and Th17 cells. Naive 
CD4+CD62Lhi DO11.10 Th cells cultured for 6 d under Th1-, Th2-, or Th17-polarizing conditions were 
restimulated with PMA/ionomycin and brefeldin A for 5 h, fixed, and stained for intracellular IL-4, 
IFN-γ, and IL-17. For cytometric analysis, cells were gated for expression of CD4. Numbers in 
quadrants indicate percentages of gated cells in each. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure S2. Ectopic overexpression of T-bet does not induce twist1 gene expression in the absence 
of IL-12. Naive DO11.10 Th cells were stimulated twice under Th1-polarizing conditions (anti-IL-4, 5 
ng/ml IL-12) or twice in the absence of IL-12 (anti-IL-4, anti-IL-12) to exclude twist1-inducing IL-
12/STAT4 signaling from analysis. On day 2, the cells were infected with control virus or a virus 
encoding t-bet. Infected cells were isolated on day 12 according to expression of the viral marker 
gene gfp. (A) Twist1 mRNA was quantified by RT-PCR after activation for 3 h with PMA/ionomycin 
and IL-2. (B) Ectopic expression of T-bet was confirmed by immunoblot. Control: α-Tubulin 
immunoblot (bottom). Data are representative of two experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure S3. Simultaneous presence of IL-12 and -4 in the culture suppresses the generation of Th1 
cells, and twist1 expression correlates to the residual fraction of IFN-γ–producing Th cells. CD62Lhi 
DO11.10 Th cells were stimulated for 6 d under Th1-polarizing conditions (5 ng/ml IL-12), under Th2-
polarizing conditions (30 ng/ml IL-4), or in the presence of both IL-12 (5 ng/ml) and -4 (30 ng/ml). (A) 
Cytokine expression profile. The cells were restimulated with PMA/ionomycin and brefeldin A for 5 h, 
fixed, and stained for intracellular IL-4 and IFN-γ. For cytometric analysis, cells were gated for 
expression of CD4. Numbers in quadrants indicate percentages of gated cells in each. (B) After 
activation for 3 h with PMA/ionomycin and IL-2, twist1 transcripts were quantified by RT-PCR. (C) 
Twist1 gene expression correlated to the frequency of IFN-γ–producing Th cells. Data are 
representative of two experiments. 
 
 
 
 
 
 
 
  
Figure S4. The twist1 gene is epigenetically imprinted in Th1 cells. The amount of acetylated 
histone 3 (left) and of trimethylated histone 3 at K4 (right) binding to the proximal twist1 promoter 
was analyzed by ChIP. 12–18-d-old Th1 and Th2 cells either in the resting state (-) or after 
restimulation with PMA/ionomycin for 3 h (+) were used. The immunoprecipitated DNA was 
quantified by RT-PCR using primers specific for the proximal promoter. The precipitated DNA was 
normalized to the amount of input DNA. The amount of twist1 transcripts precipitated in activated 
Th1 cells was set to 1. Data represent the mean ± the SD of three experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure S5. Twist1suppresses the expression of cytokines. DO11.10 Th cells were stimulated under 
Th1- or Th2-polarizing conditions or without supplementation with cytokines (neutral). On day 2, 
cells were infected with control virus or twist1-encoding virus. The cells were restimulated on day 6 
in the presence of brefeldin A and stained for intracellular cytokine expression. Frequencies of 
cytokine-expressing cells among infected, i.e., GFP+CD4+, cells are displayed. Data are representative 
of at least three experiments. 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure S6. Ectopic expression of twist1 and I-κBαM results in comparable protein levels in Th1 
cells. Th cells were stimulated with OVA327-339, APCs, and 1 ng/ml IL-12. On day 2, cells were 
infected with control virus, twist1-encoding virus, or I-κBαM–encoding virus. On day 4, the cells were 
sorted according to expression of the viral marker gene gfp. Twist1 and I-κBαM protein expression in 
GFP+ Th cells was compared with control Th cells. Control: α-Tubulin immunoblot (bottom). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure S7. The migration of young Th1 cells overexpressing twist1 is comparable to control Th1 
cells in a DTH response. Naive DO11.10 Th cells were stimulated under Th1-polarizing conditions. On 
day 2, cells were infected with control virus or a twist1-encoding virus. On day 6, infected GFP+ Th 
cells were radiolabeled and injected i.v. into BALB/c mice 1 d after induction of the DTH response. 24 
h later, radioactivity recovered from indicated organs (pLN, peripheral LNs; mLN, mesenteric LNs) 
was determined using a γ-counter (mean ± SD; n = 4). Data are representative of two experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure S8. Immunohistochemical analysis of the inflammatory response in murine antigen-
specific arthritis. Top row displays hematoxylin and eosin staining of knee joints. In the bottom rows, 
magnification showing increased fibrous tissue and vascularization (Elastica van Gieson [EvG] 
staining; arrows), Gr-1+ granulocytes at the surface of the synovium and focal accumulation of 
F4/80+ macrophages after transfer of Th1 cells expressing a twist1-targeting shRNA compared with 
control Th1 cells. Data are representative of knee joints from five mice each. Bar, 100 µm. 
 
 
 
 
 
 
 
 
 
  
 
Figure S9. IFN-α does not induce twist1 gene expression in the absence of IL-12. CD62Lhi DO11.10 
Th cells were stimulated for 6 d under Th1-polarizing conditions, under Th2-polarizing conditions, or 
in the presence of increasing levels of IFN-α and blocking IL-4 and -12 (addition of anti-IL-12 and anti-
IL-4). Twist1 mRNA of Th cells activated for 3 h with PMA/ionomycin and IL-2 was quantified by RT-
PCR. Data are representative of two experiments. 
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Table S1. Genes differentially expressed in once- versus four-time stimulated Th1 cells 
Affymetr_No Gene symbol Gene name Fold change t test 
P value 
97994_at Tcf7 Transcription factor 7, T cell specific 50.7 6.47485E-09 
104578_f_at 3110023F10Rik RIKEN cDNA 3110023F10 gene 11.9 7.10526E-09 
102282_g_at Tnfrsf7 TNF receptor superfamily, member 7 7.2 3.15546E-05 
160667_at Evl Ena-vasodilator stimulated phosphoprotein 6.6 3.20332E-07 
96672_at 2300002F06Rik RIKEN cDNA 2300002F06 gene 3.4 0.000107159 
95333_at Il18rap IL-18 receptor accessory protein 3.4 9.00834E-06 
102914_s_at Bcl2a1b B cell leukemia/lymphoma 2 related protein A1b 3.5 2.70088E-07 
97885_at 1810009M01Rik RIKEN cDNA 1810009M01 gene 4.2 1.42213E-07 
97949_at Fgl2  fibrinogen-like protein 2 4.4 9.86764E-07 
96605_at 0610011I04Rik RIKEN cDNA 0610011I04 gene 4.7 9.8031E-07 
99370_at Klrc1 Killer cell lectin-like receptor subfamily C, member 1 7.5 4.1522E-07 
103024_at Adam8 A disintegrin and metalloprotease domain 8 9.9 7.20938E-06 
99051_at S100A4 S100 calcium binding protein A4 10.5 1.27979E-06 
97519_at Spp1 Secreted phosphoprotein 1 12.9 1.84635E-06 
99957_at Mmp9 Matrix metalloproteinase 9 19.0 9.75999E-07 
98028_at Twist1 Twist gene homolog, (Drosophila) 38.8 7.14961E-05 
Naïve DO11.10 cells were activated under Th1-polarizing conditions. The transcriptional profiles of resting 6-d-old Th1 cells and resting 24-d-old Th1 cells 
were compared using Affymetrix Murine Genome (MG) U74Av2 GeneChip arrays. The Affymetrix probe set ID (Affymetr_No), mean fold change, significance of 
differential expression (t test), and mean signal intensity (Th1 6 d, Th1 24 d) of three arrays per group representing three independent cultures are shown. 
Genes were filtered according to the following criteria: fold change ≥ 2; difference of means ≥ 200; P value ≤ 0.05. 
 
 
Table S2. Clinical characteristics of patients in the study  
Patient ID Relative  twist1 mRNA 
Sex 
(male/female) 
Age 
(yr) 
Sampling 
Date (mo/yr) 
Disease duration 
(yr) ESR 
CRP 
(mg/l) 
Endoscopic biopsies from ulcerative colitis (UC) patients 
UC1 414.8 m 48 01/04 3 103 0.4 
UC1 195.7   04/04  88 0.3 
UC2 47.6 m 30 05/04 9 63 1.7 
UC3 32.8 f 38 11/04 8 94 9.13 
UC4 27.3 f 33 12/04 6 NA 19.6 
UC5 2.7 m 26 12/04 <1 NA 49.8 
UC6 83.0 m 42 7/05 6 NA 3.5 
UC7 47.4 m 44 8/05 5 NA 14.9 
UC8 40.7 m 18 11/05 2 30 10 
UC9 10.9 m 67 12/05 15 88 25 
Endoscopic biopsies from Crohn’s disease patients 
CD1 72.9 m 25 12/04 4 NA 43 
CD2 27.9 f 45 2/05 11 NA NA 
CD3 23.8 f 41 3/05 <1 NA 114.4 
CD4 31.8 f 22 7/05 3 NA 31.3 
CD5 12.7 f 34 8/05 5 NA 53.4 
CD6 13.3 f 21 11/05 5 27 10 
CD7 27.8 f 39 12/05 10 95 18 
Synovial fluid from rheumatoid arthritis patients 
RA1 30.8 m 68 03/04 1 NA 39.3 
RA2 12.5 f 40 02/05 13 10 12.3 
RA2 10.1   06/05  12 6 
RA3 6.0 f 51 04/05 11 70 39 
RA4 15.9 m 68 08/05 1 30 14 
RA4 25.5   11/05  NA NA 
Synovial fluid from reactive arthritis patients 
ReA1 30.0 m 28 03/04 1 25 35 
ReA2 7.4 m 43 06/05 <1 50 116.4 
ReA3 9.2 m 31 11/05 1 10 0.3 
Synovial fluid of psoriatic arthritis patients 
PsA1 54.9 m 55 03/04 10 9/22 0.3 
PsA2 14.2 m 68 02/05 2 39 34 
PsA3 32.7 m 50 07/05 19 NA NA 
PsA3 24.1   09/05  NA NA 
Synovial fluid from ankylosing spondylitis patients 
AS1 296.1 m 38 03/04 18 42 49 
AS1 171.1   08/04  20 3 
AS1 130.1   09/04  NA NA 
AS1 168.3   03/05  30 14.6 
AS1 138.6   09/05  20 3.1 
AS2 13.6 m 73 07/04 8 65 NA 
AS2 9.4   12/04  NA NA 
AS3 2.4 m 20 12/04 5 70 86 
AS4 61.3 m 27 02/05 18 NA NA 
AS5 5.5 m 21 10/05 1.5 80 4.5 
Not included in Fig. 5 B 
Crohn’s disease 15.5 NA NA 08/04 surgical specimen 
Crohn’s disease 45.9 NA NA 11/05 surgical specimen 
Rheumatoid arthritis 40.8 NA NA 08/04 NA NA NA 
Rheumatoid arthritis 14.8 NA NA 09/04 NA NA NA 
undifferentiated SpA 37.9 f 37 02/05 1.5 20 2 
undiff. SpA 12.8 m 44 09/06 NA NA NA 
undiff. arthritis 3.0 m 48 8/05 1 18 6 
Lyme arthritis 15.4 m 37 02/05 <1 38 7 
Lyme arthritis 3.5 m 21 06/05 2 NA NA 
Juvenile RA 42.8 f 20 11/05 6 18 1.3 
 
Twist1 transcripts in CD3+CD4+ cells purified from patient material were quantified after 3 h of 
restimulation with PMA/ionomycin. The mean expression of twist1 mRNA in total peripheral 
CD3+CD4+ cells from healthy donors was set to 1. ESR, erythrocyte sedimentation rate (ESR); 
CRP, C-reactive protein. 
 
  
Table S3. Genes differentially expressed upon ectopic twist1 overexpression 
Splenic DO11.10 cells were activated in vitro with the cognate peptide OVA327-339 in the presence of 1 ng/ml IL-12 and 1 ng/ml IL-2. On day 2, cells were 
infected with control virus or twist1-encoding virus. On day 5, cells were sorted according to expression of the viral marker gene gfp. Cells were restimulated 
for 4 h with PMA/ionomycin. The transcriptional profiles of duplicates of cultures were compared using Affymetrix Murine Genome (MG) 430A 2.0 GeneChip 
arrays. The Affymetrix probe set ID (Affymetr_No), mean fold change, significance of differential expression (t test), and mean signal intensity (Vector, Twist1) 
of two arrays per group are shown. Genes were filtered according to the following criteria: fold change  1.5; difference of means  200; P value  0.05; 
and excluding immunoglobulin genes. 
Affymetr_No Gene symbol Gene name Fold 
change 
t test 
P value 
Vector Twist1 
1449216_at Itgae integrin, E, epithelial-associated 5.8 0.003675582 45 257
1432466_a_at Apoe apolipoprotein E 3.5 0.000333012 173 425
1419532_at Il1r2 IL-1 receptor, type II 2.8 1.90721E-13 784 2,192
1415812_at Gsn gelsolin 2.4 0.000427877 541 1,282
1427076_at Mpeg1 macrophage expressed gene 1 2.1 0.027175171 168 377
1456393_at Pdcd4 programmed cell death 4 2.0 0.000960162 800 1,573
1423089_at Tmod3 tropomodulin 3 2.0 2.63289E-06 422 875
1426519_at P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxygenase 1.9 0.030113345 233 445
1415947_at Creg cellular repressor of E1A-stimulated genes 1.9 2.00686E-06 832 1,571
1448710_at Cxcr4 chemokine (C-X-C motif) receptor 4 1.8 0.029381152 237 529
1455976_x_at Dbi diazepam binding inhibitor 1.7 0.001908118 1,340 2,276
1450194_a_at Myb myeloblastosis oncogene 1.7 0.006922509 221 443
1417302_at Rcor RE1-silencing transcription factor co-repressor 1.7 0.013680996 173 384
1428301_at 2610042L04Rik RIKEN cDNA 2610042L04 gene 1.7 4.57606E-05 394 707
1438390_s_at Pttg1 pituitary tumor-transforming 1 1.7 0.001249245 625 1,044
1418126_at Ccl5 chemokine (C-C motif) ligand 5 1.6 0.014298725 937 1,699
1448021_at ESTmz98f08.r1  ESTmz98f08.r1  1.6 0.015998701 806 1,337
1418744_s_at Tesc tescalcin 1.6 6.11991E-05 841 1,507
1424112_at Igf2r insulin-like growth factor 2 receptor 1.6 0.010457946 731 1,132
1460419_a_at Prkcb protein kinase C,  1.6 0.006315009 487 815
1419550_a_at Stk39 serine/threonine kinase 39, STE20/SPS1 homologue  1.6 0.002358995 321 528
1425923_at Nmyc1 neuroblastoma myc-related oncogene 1 1.6 0.003631455 7,548 11,408
1449109_at Socs2 suppressor of cytokine signaling 2 1.6 0.001896075 805 1,319
1426397_at Tgfbr2 TGF receptor II 1.6 0.000741228 2,286 3,306
1426970_a_at Ube1l ubiquitin-activating enzyme E1-like 1.6 0.030406184 297 511
1422414_a_at Calm2 calmodulin 2 1.6 1.80435E-08 1,587 2,338
1433504_at Pygb brain glycogen phosphorylase 1.5 0.00183523 514 757
1450662_at Tesk1 testis specific protein kinase 1 1.5 0.000560519 766 1,187
1450446_a_at Socs1 suppressor of cytokine signaling 1 1.5 0.000193353 936 1,366
1455065_x_at Gnpda1 glucosamine-6-phosphate deaminase 1 -1.5 0.00169187 1,430 956
1448548_at Tulp4 tubby like protein 4 -1.5 2.19399E-05 1,144 820
1452026_a_at Pla2g12a phospholipase A2, group XIIA -1.5 0.013979562 1,228 826
1449990_at Il2 IL-2 -1.5 0.000138665 8,582 5,654
1449273_at Cyfip2 cytoplasmic FMR1 interacting protein 2 -1.5 0.000719924 1,325 983
1417240_at Zyx zyxin -1.5 0.000445837 876 601
1425787_a_at Sytl3 synaptotagmin-like 3 -1.5 6.82725E-06 2,239 1,478
1426245_s_at Mapre2 microtubule-associated protein, RP/EB family, 2 -1.5 0.022816609 1,224 791
1417679_at Gfi1 growth factor independent 1 -1.5 8.3341E-05 2,506 1,619
1423467_at Ms4a4b membrane-spanning 4-domains A, member 4B -1.5 0.001242527 4,717 3,005
1456226_x_at Ddr1 discoidin domain receptor family, member 1 -1.6 0.004473965 593 367
1425947_at Ifng interferon  -1.6 0.018605196 6,646 4,323
1426816_at Ccdc64 coiled-coil domain containing 64  -1.6 0.000603641 705 438
1422473_at Pde4b phosphodiesterase 4B, cAMP specific -1.6 1.66039E-05 1,133 627
1420965_a_at Enc1 ectodermal-neural cortex 1 -1.7 0.001533107 1,510 894
1421065_at Jak2 Janus kinase 2 -1.8 1.41758E-07 4,700 2,734
1419561_at Ccl3 chemokine (C-C motif) ligand 3 -1.8 0.03228739 3,034 1,616
1450387_s_at Ak3l1 adenylate kinase 3 alpha-like 1 -1.8 5.09427E-06 744 427
1415995_at Casp6 caspase 6 -1.8 0.000232808 1,137 573
1419412_at Xcl1 chemokine (C motif) ligand 1 -1.9 0.001140306 2,274 1,208
1422812_at Cxcr6 chemokine (C-X-C motif) receptor 6 -1.9 0.000118139 739 375
1416593_at Glrx1 glutaredoxin 1 (thioltransferase) -2.0 0.000130173 853 444
1449911_at Lag3 lymphocyte-activation gene 3 -2.0 0.000660697 1,455 638
1416899_at Utf1 undifferentiated embryonic cell transcription factor 1 -2.0 0.000102794 663 378
1416926_at Trp53inp1 transformation related p53 inducible nuclear protein 1 -2.1 0.00167533 2,514 1,087
1421578_at Ccl4 chemokine (C-C motif) ligand 4 -2.1 0.000600675 7,169 3,053
1419247_at Rgs2 regulator of G-protein signaling 2 -2.2 8.12651E-06 830 385
1416871_at Adam8 a disintegrin and metalloprotease domain 8 -2.5 0.000112885 716 281
1417256_at Mmp13 matrix metalloproteinase 13 -3.4 1.70802E-06 689 190
  
 
 
Table S4. Twist1 knock-down results in a higher inflammatory response in murine arthritis 
 Acute inflammation Chronic inflammation Sum 
Mouse Exudate Gran. inf. 
SM 
Fibrin Periart. 
gran. 
Hyperpl. Mono. inf 
SM 
Peri. mono. Cartilage 
destr. 
Acute Chronic 
scrT1 0 1 0 0 0 0.5 0 0 1 0.5
scrT2 0 1 0 0 1 1 2 0 1 4
scrT3 0 1 1 0 0 0.5 0 0 2 0.5
scrT4 1 1 1 0 0 1 0 0 3 1
scrT5 0 1 1 0 0 1 0 0 2 1
Twist1 1 1 1 1 0 1.5 1 0 4 2.5
Twist2 1 2 1 1 1 2 1 0 5 4
Twist3  1 2 1 1 1 1.5 1 0 5 3.5
Twist4 2 3 1 1 1 2 1 1 7 4
Twist5 2 3 1 1 0 2 2 1 7 4
After i.v. cell transfer of 12-d-old GFP+ DO11.10 Th1 cells expressing twist1-targeting shRNA (Twist1–5) or scrambled twist1 control shRNA (scrT1–5), arthritis 
was induced in the recipient SCID mice by intraarticular injection of cationized OVA into the knee joint. 21 d later, knee joint sections were stained for 
hematoxylin/ eosin and scored for exudates, granulocyte infiltration (gran. inf. SM), hyperplasia (hyperpl.), fibroblast proliferation/ mononuclear cell infiltration 
(mono. inf. SM), periarticular mononuclear cell infiltration (peri. mino.; each scoring 0–3), bone/cartilage destruction (scoring 0–4), and an additional score of 1 
for fibrin deposition and periarticular granulocyte infiltration (periart. gran), resulting in a maximum score of 21. 
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Table S5. Primer sequences 
 Construction of shRNA-expression retrovirus 
XbaI EF1aGFP forward TTCTAGAGACGATAAGCTTTGCAAAGATG 
EcoR5 EF1aGFP reverse TGATATCCATATGACTAGTCCCCGAAGTTG 
shTwist1 forward TGCTGAGCAAGATTCAGACCTTCAAGAGAGGTCTGAATCTTGCTCAGCTTTTTTC 
shTwist1 reverse TCGAGAAAAAAGCTGAGCAAGATTCAGACCTCTCTTGAAGGTCTGAATCTTGCTCAGCA 
scr shTwist1 forward TGCTATCGAGAAGATCAGCCTTCAAGAGAGGCTGATCTTCTCGATAGCTTTTTTC 
scr shTwist1 reverse TCGAGAAAAAAGCTATCGAGAAGATCAGCCTCTCTTGAAGGCTGATCTTCTCGATAGCA 
XhoI U6shRNA forward TATCTCGAGCAGAGATCCAGTTTGGTTAGTACC 
U6shRNA reverse TAGGTCCCTCGACCTGCTGG 
  
 Construction of protein expression retrovirus 
BglII mTbet forward ATGGAAGATCTATGGGCATCGTGGAGCC 
XhoI mTbet reverse ATCCGCTCGAGTCAGTTGGGAAAATAATTATAAAAC 
BglII mTwist1 forward GAAGATCTATGATGCAGGACGTGTCCAGC  
XhoI mTwist reverse ATCCGCTCGAGCTAGTGGGACGCGGACATGG 
BglII hMIkBa forward ATGGAAGATCTATGTTCCAGGCGGCCGA 
SalI hMIkBa reverse TTCGTCGACTCATAACGTCAGACGCTGGC 
  
 Real-time PCR
Murine HPRT forward GCTGGTGAAAAGGACCTCT 
Murine HPRT reverse CACAGGACTAGAACACCTGC 
Murine Twist2 forward GCATCCTGGCCAACGTGC 
Murine Twist2 reverse TCCATGCGCCACACGGAG 
Murine Twist1 forward CGCACGCAGTCGCTGAACG 
Murine/hum Twist1 reverse GACGCGGACATGGACCAGG 
Human Twist1 forward GGCACCCAGTCGCTGAACG 
Human UbcH5 forward TCTTGACAATTCATTTCCCAACAG 
Human UbcH5 reverse TCAGGCACTAAAGGATCATCTGG 
 
 
 
